In this study, we produced evidence that miR-214 is differentially expressed in PASMCs harvested from COPD patients with PH and that miR-214 can enhance the proliferation of PASMCs by targeting CCNL2. The gene discussed is CCNL2; the disease is chronic obstructive pulmonary disease.